P
Pietro Invernizzi
Researcher at University of Milano-Bicocca
Publications - 375
Citations - 21476
Pietro Invernizzi is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Primary biliary cirrhosis & Medicine. The author has an hindex of 70, co-authored 300 publications receiving 17005 citations. Previous affiliations of Pietro Invernizzi include Boston Children's Hospital & University of California, Davis.
Papers
More filters
Journal Article
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
Ulrich Beuers,Kirsten Muri Boberg,Roger W. Chapman,Olivier Chazouillères,Pietro Invernizzi,David Jones,Frank Lammert,Albert Parés,Michael Trauner +8 more
TL;DR: The clinical care for patients with cholestatic liver diseases has advanced considerably during recent decades thanks to growing insight into pathophysiological mechanisms and remarkable methodological and technical developments in diagnostic procedures as well as therapeutic and preventive approaches.
Journal ArticleDOI
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales,Jesus M. Banales,Jesus M. Banales,Jose J.G. Marin,Jose J.G. Marin,Angela Lamarca,Angela Lamarca,Pedro M. Rodrigues,Shahid A. Khan,Lewis R. Roberts,Vincenzo Cardinale,Guido Carpino,Jesper B. Andersen,Chiara Braconi,Diego F. Calvisi,Maria J. Perugorria,Maria J. Perugorria,Luca Fabris,Luca Fabris,Luke Boulter,Rocio I.R. Macias,Rocio I.R. Macias,Eugenio Gaudio,Domenico Alvaro,Sergio A. Gradilone,Mario Strazzabosco,Mario Strazzabosco,Marco Marzioni,Cédric Coulouarn,Laura Fouassier,Chiara Raggi,Pietro Invernizzi,Joachim C. Mertens,Anja Moncsek,Sumera Rizvi,Julie K. Heimbach,Bas Groot Koerkamp,Jordi Bruix,Jordi Bruix,Alejandro Forner,Alejandro Forner,John Bridgewater,Juan W. Valle,Juan W. Valle,Gregory J. Gores +44 more
TL;DR: This expert Consensus Statement, endorsed by the ENS-CCA, summarizes the latest advances in CCA, including classification, genetics and treatment, and provides recommendations for CCA management and priorities across basic, translational and clinical research.
Journal ArticleDOI
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales,Vincenzo Cardinale,Guido Carpino,Marco Marzioni,Jesper B. Andersen,Pietro Invernizzi,Guro Elisabeth Lind,Trine Folseraas,Stuart J. Forbes,Laura Fouassier,Andreas Geier,Diego F. Calvisi,Joachim C. Mertens,Michael Trauner,Antonio Benedetti,Luca Maroni,Javier Vaquero,Rocio I.R. Macias,Chiara Raggi,Maria J. Perugorria,Eugenio Gaudio,Kirsten Muri Boberg,Jose J.G. Marin,Domenico Alvaro +23 more
TL;DR: This Consensus Statement aims to provide valuable information on classifications, pathological features, risk factors, cells of origin, genetic and epigenetic modifications and current therapies available for this cancer.
Journal ArticleDOI
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens,Pietro Andreone,Giuseppe Mazzella,Simone I. Strasser,Christopher L. Bowlus,Pietro Invernizzi,J.P.H. Drenth,Paul J. Pockros,Jaroslaw Regula,Ulrich Beuers,Michael Trauner,David Jones,Annarosa Floreani,Simon Hohenester,Velimir A. Luketic,Mitchell L. Shiffman,K.J. van Erpecum,Victor Vargas,Catherine Vincent,Gideon M. Hirschfield,Hemant Shah,Bettina E. Hansen,Keith D. Lindor,Hanns-Ulrich Marschall,Kris V. Kowdley,R. Hooshmand-Rad,T. Marmon,S. Sheeron,R. Pencek,Leigh MacConell,Mark Pruzanski,David Shapiro +31 more
TL;DR: Obeticholic acid administered with ursodiol or as monotherapy for 12 months in patients with primary biliary cholangitis resulted in decreases from baseline in alkaline phosphatase and total bilirubin levels that differed significantly from the changes observed with placebo.
Journal ArticleDOI
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆
Carlo Selmi,Carlo Selmi,Marlyn J. Mayo,Nancy Bach,Hiromi Ishibashi,Pietro Invernizzi,Robert G. Gish,Stuart C. Gordon,Harlan I. Wright,Bruce Zweiban,Mauro Podda,M. Eric Gershwin +11 more
TL;DR: The concordance rate of PBC in identical twins is among the highest reported in autoimmunity, and discordant pairs were identified, indicating that either epigenetic factors and/or environment play a critical role.